| Financier | Commitments |
|---|---|
| IDA Credit | 150.00 |
Nigeria Polio Eradication Support Project Additional Financing
Development Objective
To assist the Recipient, as part of a global polio eradication effort, to achieve and sustain at least 80 percent coverage with oral polio vaccine immunization in every state in the Recipient’s territory, and improve national routine immunization coverage.
Key Details
Project Details
P165247
Closed
Ayodeji Odutolu , Ana Besarabic
Federal Ministry of Finance,Federal Ministry of Finance
April 4, 2018
(as of board presentation)
June 27, 2018
N/A
US$ 150.00 million
National Primary Health Care Development Agency
2018
US$ 150.00 million
B
March 27, 2024
April 30, 2021
Yes
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 150.00 |
| IBRD + IDA Commitment | 150.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 150.00 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
Detailed Financial Activity as of February 28, 2025
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Immunization coverage of OPV in the country Value 91.80 97.70 80.00 Date April 15, 2012 May 31, 2018 December 31, 2020 Comment Immunization coverage of OPV in each high risk state Value 89.00 97.70 80.00 Date December 31, 2012 May 31, 2018 December 31, 2020 Comment Direct project beneficiaries Value 0.00 17040185.00 6561446.00 Date July 9, 2012 October 30, 2015 December 31, 2018 Comment Pentavalent 3 coverage rate Value 52.00 57.00 52.00 Date May 5, 2014 November 14, 2018 December 31, 2018 Comment Female beneficiaries Value 0.00 50.00 50.00 Date July 9, 2012 October 30, 2015 December 31, 2018 Comment Number of LGAs with Pentavalent 3 coverage among children under 12 months <50% in the 12 lagging states Value 123.00 123.00 41.00 Date December 18, 2017 December 18, 2017 December 31, 2020 Comment Pentavalent 3 coverage among children under 12 months in 12 lagging states Value 23.25 40.00 33.00 Date December 18, 2017 November 14, 2018 December 31, 2020 Comment Number of LGAs with Pentavalent 3 coverage among children under 12 months <25% in the 12 lagging states Value 71.00 71.00 24.00 Date December 18, 2017 December 18, 2017 December 31, 2020 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of teams with viable vaccine according to the Vaccine Vial Monitor Value 97.00 100.00 98.00 Date April 15, 2012 October 31, 2018 December 31, 2020 Comment Percentage of campaigns where vaccines are available on time Value 100.00 100.00 100.00 Date July 9, 2012 October 31, 2018 December 31, 2020 Comment